Summary
- Current Price
- As of today, KLRS price is $2.85, down -1.38% on
- Current Price All-Time High
- KLRS price is currently -99.75% below its historical high of $1,126.08 set on
- Market Cap
- KLRS current market cap is $68M, down -40.24% year-over-year
- Revenue
- KLRS current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for KLRS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Kalaris Therapeutics, Inc. |
| Ticker | NASDAQ: KLRS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kalaristx.com |
| Employees | 14 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $2.85 | ||
| Price, 1D Change | -1.38% | |
| $68M | ||
| - | ||
| - | ||
| 1.01 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.85 | ||
| EPS, 1Y Change | +94.50% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:23 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ALVR | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.85 | ||
| EPS Estimate | -$2.01 | N/A |
| EPS Est. Change | +29.44% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $2.85 | ||
| Price Target | $20.00 | - |
| Price Tgt. Change | +601.75% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$51.77 | - | |
| -$3.70 | -$2.85 | +23.04% | |
| -$2.01 | N/A | +29.44% | |
| -$1.66 | N/A | +41.70% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $11.43M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -53.05% | ||
| -94.24% | ||
| -40.24% | ||
| -72.31% | ||
| 0.00% | ||
| 0.00% | ||
| +94.50% | ||
| +94.38% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $2.85 | ||
| $6.13 | ||
| $3.66 | ||
| $5.20 | ||
| $3.65 | ||
| -$0.26 | ||
| 1.01 | ||
| $0.19 | ||
| 25.07 | ||
| 35.93% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.85 | ||
| $0.00 | ||
| - | ||
| -$46.15M | ||
| - | ||
| -$43.44M | ||
| - | ||
| -$46.14M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 12.23 | ||
| 12.23 | ||
| - | ||
| - | ||
| -1.07 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 1.18 | ||
| 0.51 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $78.81M | ||
| $117.98M | ||
| $121.74M | ||
| $118.81M | ||
| $42.92M | ||
| $9.71M | ||
| $1.45M | ||
| $316.00K | ||
| $1.28M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $43.44M | ||
| $46.15M | ||
| $13.00K | ||
| $0.00 | ||
| $13.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$42.98M | ||
| -$19.72M | ||
| $159.61M | ||
| $200.00K | ||
| -$43.18M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| TD Cowen | ||
| Wedbush | ||
| Citizens | → | |
| Morgan Stanley | ||
| Chardan Capital | ||
| Citizens | ||
| Raymond James | ||
| William Blair |
Analyst sentiment
Institutional ownership
Screeners with KLRS
FAQ
- What is the ticker symbol for Kalaris Therapeutics, Inc.?
- The ticker symbol for Kalaris Therapeutics, Inc. is NASDAQ:KLRS
- Does Kalaris Therapeutics, Inc. pay dividends?
- No, Kalaris Therapeutics, Inc. does not pay dividends
- What sector is Kalaris Therapeutics, Inc. in?
- Kalaris Therapeutics, Inc. is in the Healthcare sector
- What industry is Kalaris Therapeutics, Inc. in?
- Kalaris Therapeutics, Inc. is in the Biotechnology industry
- What country is Kalaris Therapeutics, Inc. based in?
- Kalaris Therapeutics, Inc. is headquartered in United States
- When did Kalaris Therapeutics, Inc. go public?
- Kalaris Therapeutics, Inc. initial public offering (IPO) was on July 30, 2020
- Is Kalaris Therapeutics, Inc. in the S&P 500?
- No, Kalaris Therapeutics, Inc. is not included in the S&P 500 index
- Is Kalaris Therapeutics, Inc. in the NASDAQ 100?
- No, Kalaris Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Kalaris Therapeutics, Inc. in the Dow Jones?
- No, Kalaris Therapeutics, Inc. is not included in the Dow Jones index
- When was Kalaris Therapeutics, Inc. last earnings report?
- Kalaris Therapeutics, Inc.'s most recent earnings report was on August 7, 2025
- When does Kalaris Therapeutics, Inc. report earnings?
- The date for Kalaris Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- KLRS Official Website kalaristx.com
- KLRS Profile on Yahoo Finance finance.yahoo.com/quote/KLRS
- KLRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/klrs